Enliven Therapeutics, Inc. 8-K

Accession 0001564590-22-010212

Filing information

CIK: 0001672619
Report date: 2022-03-15
Filing date: 2022-03-15
Form: 8-K
Primary document: imra-8k_20220315.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.